News

Wedgewood Pharmacy is compounding oseltamivir phosphate in a cherry-flavored suspension in response to the nationwide shortage of Tamiflu suspension. The commercially manufactured Tamiflu product, from F Hoffmann-La Roche,

NeurogesX has received approval from FDA for Qutenza (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to

Artes Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm have reported the successful production of a new target of a therapeutic protein. This is the first result

NovaDel Pharma (NovaDel) has enter into an exclusive license and distribution agreement with ECR Pharmaceuticals, a wholly owned subsidiary of Hi-Tech Pharmacal to commercialise and manufacture ZolpiMist in the

Sanofi Pasteur has reported that the French drug agency has granted marketing authorisation in France for Panenza, its non-adjuvanted Influenza A(H1N1) 2009 monovalent vaccine. The vaccine was made

GlaxoSmithKline (GSK) and Nabi Biopharmaceuticals (Nabi) have reported a licensing agreement for a nicotine conjugate candidate vaccine (NicVAX), and for the development of a second generation nicotine vaccine.

MeadWestvaco (MWV) has released the results of a study that the company commissioned on packaging damage. Results revealed that damaged packaging has a profound effect on shoppers’ purchasing

India-based Glenmark has entered into an exclusive license agreement with Medicis Pharmaceutical to co-develop and commercialise a specialty pharmaceutical product in North America. The product will be used

Catalent Pharma Solutions has received ISO 15378 certification of its Printed Components facility in Dublin, Ireland. Reportedly, Catalent is the first secondary packaging company in Ireland to achieve